Lupus nephritis is associated with poor pregnancy outcomes in pregnant SLE patients in Cape Town: a retrospective analysis by Mbuli, Lindisa et al.




Lupus nephritis is associated with poor pregnancy outcomes in pregnant SLE patients 
in Cape Town: a retrospective analysis 
 
Lindisa Mbuli1, Darlington Mapiye2, Ikechi Okpechi1,3,& 
 
1Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa,2South Africa National Bioinformatics 
Institute (SANBI), University of the Western Cape, Cape Town, South Africa, 3Division of Nephrology and Hypertension, University of Cape Town, 
Cape Town, South Africa 
 
&Corresponding author: Ikechi Okpechi, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa, 
Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa 
 
Key words: Lupus, Africans, pregnancy, maternal, foetal, neonatal, pre-eclampsia, SLE 
 
Received: 05/09/2015 - Accepted: 01/12/2015 - Published: 14/12/2015 
 
Abstract  
Introduction: Systemic lupus erythematosus (SLE) is a multi-system auto-immune disease common in females of child-bearing age. The effect of 
pregnancy on SLE and vice versa have not been well characterised in Africans. The aim of this study is to describe the pregnancy outcomes of 
patients with SLE presenting to the maternity department of Groote Schuur Hospital, Cape Town. Methods: This study was designed as a 
retrospective review of records of pregnant women known with SLE and followed-up at the maternity section of Groote Schuur Hospital. The 
duration of survey was from the 1st January 2003 to 31st December 2013. Results: There were 61 pregnancies reviewed in 49 patients; 80.3% of 
the pregnancies were in patients of mixed ancestry and the rest (19.7%) in black African patients. The mean age at presentation of the current 
pregnancy was 27.2±5.0 years. Mean gestational age at presentation and delivery was 13.0 ± 6.0 weeks and 28.9 ± 9.8 weeks respectively and 
47.5% of the pregnancies were in patients with lupus nephritis (LN). Thirty nine (63.9%) pregnancies reached the third trimester and 11.5% of all 
pregnancies ended in the first trimester. There was a lower number of live births to mothers of African ancestry than to those of mixed ancestry 
(p=0.001). In 55.7% of the pregnancies, no flare was reported while a renal flare was reported in 23%. Pregnancies in patients with LN had 
higher frequencies of flares (58.6% vs 31.3%; p=0.032), pre-eclampsia (34.5% vs 12.5%; p=0.041), longer stay in hospital (12.0 ± 9.1 days vs 
6.1 ± 5.1 days; p=0.004) and low birth weight babies (1.94 ± 1.02 kg vs 2.55±0.95 kg; p=0.046) than in patients without LN. Only 36 (59%) of 
the neonates were discharged home alive and of these 2 (5.6%) were to mothers of black African ancestry (p=0.001). Conclusion: Increased 
lupus activity in pregnant SLE patients may account for the increased deaths of neonates born to SLE mothers. Patients of black African descent 
and those with LN tend to have a poorer outcome. A multi-disciplinary approach to the management of SLE patients (of child-bearing age or 
pregnant) needs to be further assessed for better outcomes. 
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Introduction 
 
Systemic lupus erythematosus (SLE) is an autoimmune disease with 
a manifestation of complex interplay between genetic factors, 
hormones, autoantibodies and environmental factors [1]. Like most 
autoimmune diseases it affects mostly women of childbearing age 
although all ageand ethnic groups are susceptible [2,3]. The 
evolution of SLE is known to be changed by natural hormonal 
events (e.g. menstrual period, menopause and pregnancy). The 
care of pregnant women with SLE as well as pregnancy outcomes in 
women with SLE has been reported to have significantly improved 
even though these reports are often from developed countries [4]. 
Pregnancy in SLE is, however still considered “high-risk” especially 
in low-income countries where all the facilities or options of therapy 
may not be available. Adverse short term and long term maternal 
outcomes that have been reported in SLE includes maternal death, 
stroke, hypertension, pre-eclampsia or eclampsia and LN with 
accelerated end organ damage requiring dialysis [5]. In one study, 
SLE patients were twice more likely to have a caesarean section and 
their neonates were more likely to be of low birth weight, preterm 
delivery and had higher frequencies of congenital malformations 
than reference patients [6]. Data is limited from countries in Africa, 
although one study has previously reported no loss to maternal life, 
13% occurrence of mild flares, 33.3% pre-eclampsia, 77% live 
births and 14% intra-uterine growth retardation [7]. We therefore 
sought to retrospectively assess the impact of pregnancy on SLE 
and vice versa at Groote Schuur Hospital, Cape Town and to 





This study was approved by the University of Cape Town Human 
Research Ethics Committee (HREC REF 038/2013). Records of 
patients known with SLE meeting the American College of 
Rheumatology criteria for SLE 1982 (revised in 1997) who presented 
to the GSH gynaecology emergency unit, ante-natal clinic or 
maternity wards in gestation from 1 January 2003 to 31December 
2013 were accessed for retrospective analysis. The patients' records 
were identified using the attendance registers in the relevant 
departments (Rheumatology and Nephrology) involved in the care 
of patients with SLE. Patients were excluded if they didn't meet the 
American College of Rheumatology criteria for SLE, if they had 
mixed connective tissue disease of those who presented to the 
Obstetrics department outside the period of the study. Records 
obtained included ethnicity, age of the patient at presentation, 
gestational age at presentation, history of chronic diseases 
(hypertension, diabetes) and current and past gynaecological and 
obstetric history. Complications that occurred during pregnancy 
such as pre-eclampsia, flare of SLE (defined as a change in clinical 
and/or serological parameters requiring adjustment of doses of 
immunosuppression were categorised as renal, skin, joint, or any 
combination of these) [8], pre-term delivery, and method of delivery 
were documented. Pre-eclampsia was as diagnosed by the 
attending obstetrician. Duration of maternal hospitalisation and 
gestational age at delivery were also recorded. Foetal outcomes 
were documented as birth weight (normal or low birth weight), 
duration of hospitalisation after delivery and status of the neonate 
at discharge (alive or died). Various terms used were defined 
following South African standards [9]: Birth weight and gestational 
age: Low birth weight: neonatal weight 1000 - 2499g; Pre-term 
baby: birth at gestational age of 28-37 weeks; Term baby: birth at 
gestational age of > 37 weeks; Pregnancy outcomes: Miscarriage: 
pregnancy loss from time of conception until 24 weeks and 28 
weeks of gestation or delivery of foetus below 500g in weight or; 
Pre-term labour: the onset of labour before 37 completed 
gestational weeks; Term labour: the onset of labour after 37 




The data were analysed using IBM SPSS Statistics 21 software 
(SPSS, Chicago, IL). Categorical variables were presented as 
percentages and continuous variables as means ± SD. Comparison 
was made between pregnancies in patients with LN and those 
without LN using the Student's t-test, chi-square test or Fisher's 





Baseline demographics features of patients 
  
Initially, we reviewed the data of 62 pregnancies in 50 women. One 
patient was excluded as there was inadequate evidence to show 
that she fulfilled the ACR criteria for the diagnosis of SLE. Hence, 
the baseline features of 61 singleton pregnancies (49 women) that 
fulfilled the ACR classification criteria for a diagnosis of SLE are 
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shown in Table 1, and 12 women had more than pregnancy during 
the course of the study. The mean age at presentation (for the 
assessed pregnancy) was 27.2 ± 5.0 years, most of the patients 
(80.3%) were of mixed ancestry and 47.5% of the pregnancies 
occurred in patients known with biopsy proven LN (Figure 1). 
Treatment records at presentation included use of glucocorticoids 
(67.2%), cyclosporine A (9.8%), Azathioprine (23.0%), chloroquine 
(50.8%) and various anti-hypertensive agents (none - 50.8%, 1 
anti-hypertensive agent - 23.0%, 2 or more anti-hypertensive 
agents - 26.2%) (not shown in Table). 
  
Maternal and foetal features and outcomes 
  
Table 2,Table 3 summarises the recorded maternal and foetal 
features and outcomes from pregnancy to time of delivery. The 
mean gestational age at delivery was 28.9 ± 9.8 weeks, most of the 
deliveries (63.9%) occurred in the third trimester of pregnancy and 
over half of deliveries (52.5%) were either by evacuation of retained 
products of conception or Caesarean section. Pre-eclampsia 
occurred in 23% of all the pregnancies. A lupus flare was 
documented in 44.3% of pregnancies; most flares predominantly 
affected the kidneys (23.0%) (Figure 2). At birth, 64% of neonates 
were born alive, 9.8% were stillbirths (Table 3 ). However, only 
59% of the neonates were discharged home alive as three infants 
died shortly after birth. The average birth weight of infants was 2.24 
± 1.02 kg and 54.5% were low birth weights. The average duration 
of hospitalisation post-delivery for neonates was 9.2 days (min - 0; 
max - 70 days). Neonates born to black African mothers significantly 
had lower survival rates than those born to mothers of mixed 
ancestry (5.6% vs 94.4%; p=0.001) (Figure 3). 
  
Differences in features and outcomes in pregnancies of 
patients with lupus nephritis and those without kidney 
involvement 
  
Table 4 shows the differences in pregnancy features and outcomes 
between patients with LN and those without LN. Importantly, 
pregnant women with LN had a higher frequency of flares (58.6% 
vs 31.3%; P=0.032), higher rate of pre-eclampsia (34.5% vs 
12.5%, P=0.041), longer duration of hospitalization (12.0 ± 9.1 vs 
6.1 ± 5.1 days; P=0.004) and lower mean birth weight of the 
neonate (1.94 ± 1.02 vs 2.55 ± 0.95 kg; P=0.046) than those 
without kidney involvement. Patients with LN had a lower neonatal 
survival (51.7%) at discharge compared to those without LN 
(65.6%), however, this was not significantly different (p=0.270) 





Systemic lupus erythematosus is predominantly a disease of women 
of child-bearing age; it is therefore not uncommon or unexpected 
that these patients may present with pregnancy and this can be 
associated with hormonal changes likely to increase activity of lupus 
and affect the outcome of pregnancy. The key findings in the 
current study relates to our observation of overall increased 
neonatal morbidity and mortality especially if born to patients 
known with LN or patients of black African ancestry. We also noted 
a relatively high neonatal mortality in comparison with the results of 
studies published elsewhere (Table 5 ) [7,10-15]. We consider the 
high neonatal mortality in our study as a reflection of the severity of 
lupus activity and not of the state of healthcare in South Africa as all 
our patients were treated in a large tertiary health care facility. 
Increased lupus activity [13], previous obstetric history (i.e. 
previous pregnancy loss) [16], renal involvement in lupus [17] and 
secondary anti-phospholipid syndrome [18] have been identified as 
predictors of pregnancy loss in patients with lupus and some of 
these factors might explain the poor outcome in our study. In one 
study, Yang et al assessing lupus activity with the SLEDAI score 
reported the incidence of preeclampsia/eclampsia, foetal loss, and 
preterm birth to be significantly higher in patients with active 
pregnancy related lupus compared to those with stable pregnancy 
related lupus (p<0.05) [19].They also reported that despite 
receiving a more vigorous glucocorticoid treatment, mothers with 
active pregnancy related lupus had a poorer prognosis compared to 
those with stable lupus in pregnancy (p<0.001) [19]. Although 
lupus activity scores were not directly assessed in our study, activity 
was indirectly measured through the occurrence of lupus flares 
which we found to be more common in those with LN (Table 4 ). 
Also, we observed that in 36.1% of mothers, there was a history of 
pregnancy loss in previous pregnancies and mothers with such 
history had a higher chance or recurrent loss of current pregnancy 
(results not shown). Ramsey-Goldman et al have shown in their 
study of SLE patients with either positive or negative anticardiolipin 
antibodies that in both groups, if there was an adverse outcome in 
their first pregnancy had at least a 50% chance of another adverse 
outcome in their second pregnancy [16].Hence, SLE patients with 
previous pregnancy loss may be at greater risk of loss of conception 
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in subsequent pregnancies. Although we did not find any significant 
correlation between previous pregnancy loss and outcome in current 
pregnancy, this may be an important factor to consider in patients 
with SLE who become pregnant. We also found that LN was 
associated with increased flare in pregnancy (p=0.032), increased 
frequency of pre-eclampsia (p=0.041), low neonatal birth weight 
(p=0.046) and increased maternal duration of hospitalization all of 
which are surrogates of poor maternal and foetal outcomes (Table 
4 ). One meta-analysis of pregnancy outcomes in patients with SLE 
and LN comprising of 1842 patients with 2751 pregnancies reported 
the rates of lupus flare, pre-eclampsia, spontaneous abortion, 
stillbirth, and neonatal deaths to be 25.6%, 7.6%, 16%, 3.6%, and 
2.5% respectively [11]. However, in a multicentre study of 81 
women (113 pregnancies) with pre-existing biopsy-proven LN that 
assessed the risk factors for complicated pregnancy (foetal loss and 
renal flares), Imbasciati et al reported nine spontaneous abortions, 
one stillbirth and five neonatal deaths [20].They also reported that 
renal flares during and after pregnancy are not uncommon and can 
be predicted by renal status assessed before pregnancy. Taken 
together, these findings show that in patients with SLE and LN there 
is an increased risk of maternal and foetal complications and further 
supports the need for timing of pregnancy relative to SLE activity 
and multispecialty care of these patients. 
  
Finally, we report from our study lower neonatal survival for those 
of black African ancestry compared to those of mixed ancestry 
(p=0.001) (Figure 3). As all the mothers and newly born would have 
received the same level of care from our hospital, this outcome is 
thought to be related to an increased severity of lupus in those of 
African ethnicity or may be due to differences in other socio-
demographic factors such as level of education, nutritional status 
and attitude relating to the use of medical facilities (the later factors 
were not assessed in this study). In this study, among patients of 
African ancestry, 58.3% had a flare during pregnancy compared to 
40.8% in those of mixed ancestry. SLE has been reported to be 
more severe in those of African descent often with less favourable 
outcomes than in Caucasians and in those of poor socio-economic 
status [21-24].In the LUMINA study, 34 of 288 SLE patients had 
died within 5 years of study onset; most were African Americans 
and some factors that were associated with mortality included 
poverty, less than full-time employment, difficulty in accessing 
health care and cardiovascular and renal involvement [23]. Ward et 
al also reports on univariate analyses of their study that mortality 
rates increased with age and were higher among males, blacks, 
those without private medical insurance, and those living in census 
tracts with lower household incomes in the US [24]. Other factors 
relevant to the ethnic variance in the outcome may be genes related 
to progression of renal disease, such as ACE polymorphisms. These 
findings support the role of race and socio-demographic factors in 
the outcome of patients with SLE and this can be extended to the 
outcomes observed in pregnancy as in our study. The higher 
severity of lupus with increased activity during pregnancy in black 
African patients may suggest that such patients will require closer 
monitoring of lupus flares and perhaps a more intensive follow-up at 
the ante-natal clinics in order to improve outcome of pregnancy. 
Our results are limited in some ways including the retrospective 
design of this study which meant that not all patients' records could 
have been obtained. For example the results of serological assays 
for SLE (anti-double stranded DNA antibodies, anti-SSA/Ro and anti-
SSB/La antibodies, antiphospholipid antibodies, C3 and C4 
compliment level) were not always available and hence not 
presented in our data. Also, the retrospective design means that the 
interpretation of flares (disease activity) was sometimes done 
retrospectively as the attending physicians made the diagnosis of 
flares differently and the small sample size of this study may be a 
limitation of how the results are interpreted; although other 





Our results suggest that pregnancy in patients with SLE is 
associated with a relatively poor maternal and foetal outcome, 
particularly in those with LN and those of African descent. There is 
need for intensive monitoring of these patients during pregnancy 
and perhaps a multi-disciplinary approach to the management of 
SLE patients, including an obstetrician (optimally a maternal foetal 
medicine specialist), a rheumatologist, and a nephrologist. 
Preconception counselling in non-pregnant SLE patients to increase 
awareness of the disease should be routinely carried where the goal 
is to optimise her health before becoming pregnant. Such an 
approach could help in reducing the relatively high maternal and 
foetal morbidity and mortality often reported in developing countries 
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Table 1: Baseline demographics features of SLE pregnancies 
Variable Frequency  (n=61)* 
Age at SLE diagnosis (Years) 23.3 ± 6.3 
Age at presentation - current pregnancy (years) 27.2 ± 5.0 
Race:   
Black Africans 12 (19.7%) 
Mixed ancestry 49 (80.3%) 
GA at presentation (weeks) 13.0 ± 6.0 
Trimester at presentation   
First 41 (67.2%) 
Second 17 (27.9%) 
Third 3 (4.9%) 
Kidney involvement in SLE:   
Lupus nephritis 29 (47.5%) 
No-lupus nephritis 32 (52.5%) 
History previous pregnancies (%):   
Primigravida 20 (32.8%) 
Others 41 (67.2%) 
* This number represents the total number of pregnancies assessed in this study 
  
Table 2: Maternal features and outcomes (n=61)* 
Variable Value 
Mean gestational age at delivery (weeks) 28.9 ± 9.8 
Trimester at time of delivery (%)   
First Trimester 11.5 
Second Trimester 24.6 
Third Trimester 63.9 
Method of delivery (%)   
Normal vaginal delivery 47.5 
Evacuation** 24.6 
Caesarean section 27.9 
Pre-eclampsia (%)         23.0 
Previous pregnancy loss # 36.1 
* -This number represents the total number of pregnancies 
assessed in this study 
** - This refers to evacuation of the retained products of conception 
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Table 3: Foetal features and outcomes  (n=61)* 
Variable Value 
Average birth weight (kg) 2.24 ± 1.2 
Birth weight (%)   
·         Low birth weight 54.5% 
·         Normal birth weight 45.5% 
Mean duration of Hospitalization (days) 9.2 (0-70) [ min –max] 
Status at birth (%)   
·         Alive 64.0 
·         Medical termination 3.3 
·         Miscarriage 23.0 
·         Stillbirth 9.8 
Outcome at discharge (%)   
·         Alive 59.0 
·         Died 41.0 
* The number represents the total number of deliveries assessed in this study 
 
 
Table 4: Differences in pregnancy outcomes between patients with lupus nephritis and patients with SLE without nephritis 





Mean gestational age at delivery (weeks) 28.0 ± 9.0 29.6 ± 10.6 0.532 
Flare (%) 58.6 31.3 0.032 
Pre-eclampsia (%) 34.5 12.5 0.041 
Mean Maternal Hospital stay (days) 12.0 ± 9.1 6.1 ± 5.1 0.004 
Pregnancy outcomes (%)     0.218 
Miscarriage 20.7 25.0   
Medical termination 6.9 0   
Still birth 10.3 9.4   
Preterm live birth 44.8 28.1   
Term live birth 17.2 37.5   
Mode of delivery (%)     0.427 
Evacuation** 24.1 25.0   
Normal vaginal delivery 55.2 40.6   
Caesarean section 20.7 34.4   
Neonatal outcomes       
Alive on discharge (%) 51.7 65.6 0.270 
Mean birth weight (kg) 1.94 ± 1.02 2.55 ± 0.95 0.046 
Mean neonatal hospitalisation (days) [Min-Max] 9.13 [1 – 70] 9.24 [0 – 52] 0.984 
** - This refers to evacuation of retained products of conception 
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Table 5:  Pregnancy outcomes reported from various studies worldwide 










China Liu et al. (2012) [10] 111 22.5 25.2 74.8 
Systemic review & meta-analysis Smyth et al. (2010) [11] 2751 16 ** 39.4 74.5 
Portugal Carvalheiras et al. (2010)[12] 51 6 16 74 
USA Clowse et al.(2005) [13] 267 7 40 85.8 
South Africa Whitelaw et al.  (2008) [7] 47 21 39 77 
India Chandran et al. (2004) [14] 52 28.6 1.9 46.1 
Taiwan Wong et al (2006) [15] 24 8.3 33.3 91.6 
This study (South Africa) Mbuli et al (2015) 61 23 36.1 64.0 
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Figure 3: Neonatal discharge outcomes by maternal race 
 
